(Q36241219)

13 August 2017

1 reference

title

Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? (English)

1 reference

13 August 2017

1 reference

Michael P Caligiuri

1

1 reference

13 August 2017

Casey Buitenhuys

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

13 August 2017

published in

Neuropsychopharmacology

1 reference

13 August 2017

volume

30

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

2125-2134

1 reference

Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

The functional anatomy of basal ganglia disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Pallidotomy for parkinson disease: a review of contemporary literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Cigarette smoking and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Monoamine oxidases and tobacco smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Parkinsonism in neuroleptic-naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Interest in smoking cessation among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Raclopride studies of dopamine release: dependence on presynaptic integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

D2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine-induced dopamine and serotonin reductions in neostriatum are not gender specific in rats with comparable hyperthermic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Focused motor stereotypies do not require enhanced activation of neurons in striosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effect of chronic administration of methamphetamine on the responsiveness of substantia nigra zona reticulata neurons to GABA or a GABA agonist in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Caudate-putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

An extrapyramidal choreiform syndrome caused by amphetamine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Expression of amphetamine-induced behavioral sensitization after short- and long-term withdrawal periods: participation of mu- and delta-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Dextroamphetamine-Sulfate-Induced Dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

"Thermoregulation-dependent component" in pathophysiology of motor disorders in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Basal ganglia intrinsic circuits and their role in behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

The pharmacological characterization of attentional processes using a two-lever choice reaction time task in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Malignant syndrome in Parkinson's disease: concept and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Why is parkinsonism not a feature of human methamphetamine users?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Acute changes in dopamine release and turnover in rat caudate nucleus following a single dose of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Pallidotomy and bradykinesia: implications for basal ganglia function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Effects of stimulus salience and methamphetamine on choice reaction time in the rat: central tendency versus distribution skew

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Dopamine displays an identical apparent affinity towards functional dopamine D1 and D2 receptors in rat striatal slices: possible implications for the regulatory role of D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Cognitive impairment in individuals currently using methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine-induced choreoathetosis and rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

A twin study of the neuropsychological consequences of stimulant abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Long-term effects of chronic methamphetamine administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Dynorphin agonist therapy of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Influence of globus pallidus on arm movements in monkeys. I. Effects of kainic acid-induced lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Does nicotine modify the psychotoxic effect of methamphetamine? Assessment in terms of locomotor sensitization in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Positron-emission tomography in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300859

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300859

1 reference

13 August 2017

1 reference